Philadelphia Business Journal

Discovery Laboratories to Develop Drug for Premature Infants

Discovery Laboratories Inc. has found a development partner for a potentially improved version of its drug used to prevent respiratory distress syndrome in infants born prematurely. 

The Warrington, Pa., biopharmaceutical company entered into a collaboration deal with Battelle, an independent research-and-development organization based in Columbus, Ohio, that has more than three decade of experience in aerosol science.

The two organizations will attempt to further develop Discovery Labs' (NASDAQ: DSCO) proprietary capillary aerosol generator for use in the Bucks County company's Aerosurf program. Read the full story here.


For more business stories, head to PBJ.com

Copyright bizjournal
Contact Us